[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334424-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334424-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pre-diagnostic-prescription-patterns-in-bladder-and-renal-cancer-a-longitudinal-linked-data-study-abstract","Pre-diagnostic prescription patterns in bladder and renal cancer - a longitudinal linked data study - Abstract","","Pre-diagnostic prescription patterns for bladder and renal cancer are examined to identify time windows when earlier cancer investigation may be possible. A retrospective cohort study uses linked electronic primary care and cancer registry data for patients diagnosed in England between April 2012 and December 2015. Prescriptions up to two years before diagnosis are analyzed across clinical feature groups, with Poisson regression used to detect inflection points signaling increased prescribing rates and potential diagnostic windows.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pre-diagnostic-prescription-patterns-in-bladder-and-renal-cancer-a-longitudinal-linked-data-study-abstract/334424/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pre-diagnostic-prescription-patterns-in-bladder-and-renal-cancer-a-longitudinal-linked-data-study-abstract/334424.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of analyzing pre-diagnostic prescribing patterns in this study?","Question",{"text":63,"@type":64},"To examine how prescribing patterns for common urological clinical features change before renal and bladder cancer diagnoses, and to identify inflection points that may define diagnostic windows.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which prescriptions and clinical features were analyzed before diagnosis?",{"text":68,"@type":64},"Primary care prescriptions up to 2 years pre-diagnosis were analyzed for five groups of clinical features: irritative urological symptoms, obstructive symptoms, urinary tract infections (UTIs), genital infections, and atrophic vaginitis.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings about UTIs before cancer diagnosis?",{"text":72,"@type":64},"UTI prescription rates increased about 9 months before both bladder and renal cancer diagnoses; for bladder cancer, the increase occurred earlier in females than in males.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334424,1790301143,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Research  \nGarth Funston, Marie Moullet, Luke Mounce, Georgios Lyratzopoulos, Fiona M Walter andYin Zhou  \nPre-diagnostic prescription patterns in bladder and renal cancer:  \na longitudinal linked data study  \nAbstract  \n\n| Background\u003Cbr>Understanding pre-diagnostic prescribing activity could reveal windows during which more timely cancer investigation and detection may occur. |\n| --- |\n| Aim\u003Cbr>To examine prescription patterns for common urological clinical features prior to renal and bladder cancer diagnoses. |\n| Design and setting\u003Cbr>A retrospective cohort study was performed using electronic primary care and cancer registry data on patients with bladder and renal cancer, who received their diagnosis between April 2012 and December 2015 in England. |\n| Method\u003Cbr>Primary care prescriptions up to 2 years\u003Cbr>pre-diagnosis were analysed for five groups of clinical features (irritative urological symptoms, obstructive symptoms, urinary tract infections [UTIs], genital infections, andatrophic vaginitis) . Poisson regressions estimating the inflection point from which the rate of prescriptions increased from baseline were used to identify the start of diagnostic windows during which cancer could be detected. |\n| Results\u003Cbr>Atotal of 48 094 prescriptions for 5322 patients were analysed. Inflection points for an increase in UTI prescriptions were identified 9 months pre-diagnosis for renal (95% confidence interval [CI] = 5.3 to 12 .7) and bladder (95% CI = 7.4 to 10.6) cancers. For bladder cancer, the change in UTI antibiotic prescription rates occurred\u003Cbr>4 months earlier in females (11 months\u003Cbr>pre-diagnosis, 95% CI = 9.7 to 12 .3) than in males (7 months pre-diagnosis, 95% CI = 5.4 to 8 .6) . For other clinical features, no inflection points were identified and, as such, no diagnostic windows could be defined. |\n| Conclusion\u003Cbr>Prescription rates for UTIs increased 9 months before bladder and renal cancer diagnoses, indicating that there is potential to expedite diagnosis of these cancers in patients presenting with features of UTI. The greatest opportunity for more timely diagnosis may be in females with bladder cancer, who experienced the earliest increase in UTI prescription rate. |\n| Keywords\u003Cbr>urinary tract infections; bladder cancer; primary health care; kidney cancer; atrophic vaginitis; renal cell cancer. |\n\nINTRODUCTION  \nIn the UK, around 13 000 and 10 000 people are diagnosed with renal and bladder cancer, respectively, each year.1,2 The majority are diagnosed after they present with urological symptoms in general practice and are, subsequently, referred for specialist investigation.3 Patients with bladder and renal cancer frequently present to primary care multiple times before diagnosis, and studies have identified the presence of potential missed opportunities for timely detection.4–6  \nClinical activities, such as primary care consultation rates and routine tests, can increase in patients many months prior to cancer diagnosis. These periods, particularly if prolonged, may represent‘windows’ in which cancer can be detected earlier in some patients.7 Understanding when and how clinical activities change during this period can help to determine the potential for more timely diagnosis.  \nStudies on colorectal cancer, Hodgkin lymphoma, lung cancer, and all cancers have demonstrated increased rates of prescriptions pre-diagnosis, both in terms of certain specific medications and when all prescriptions were examined collectively.8–12 The authors of the study presented here have previously examined pre-diagnostic primary care blood  \ntests and secondary care imaging test patterns in patients with bladder and renal cancer, but are not aware of any studies exploring prescription patterns prior to the diagnoses of these malignancies.13,14 In this study, patterns of relevant primary care prescriptions for urological symptoms and conditions in the 24 months before renal and bladder cancer diagnoses were examined. The authors ","cbCaipVOLYTNIowK","https://ap.wps.com/l/cbCaipVOLYTNIowK","pdf",217235,"English","# Abstract\n## Background\n## Aim\n## Design and setting\n## Method\n## Results\n## Conclusion\n# Introduction\n## Clinical pathways and missed opportunities\n## Prior evidence from other cancers\n# Method\n## Study design","[{\"question\":\"What is the main purpose of analyzing pre-diagnostic prescribing patterns in this study?\",\"answer\":\"To examine how prescribing patterns for common urological clinical features change before renal and bladder cancer diagnoses, and to identify inflection points that may define diagnostic windows.\"},{\"question\":\"Which prescriptions and clinical features were analyzed before diagnosis?\",\"answer\":\"Primary care prescriptions up to 2 years pre-diagnosis were analyzed for five groups of clinical features: irritative urological symptoms, obstructive symptoms, urinary tract infections (UTIs), genital infections, and atrophic vaginitis.\"},{\"question\":\"What were the key findings about UTIs before cancer diagnosis?\",\"answer\":\"UTI prescription rates increased about 9 months before both bladder and renal cancer diagnoses; for bladder cancer, the increase occurred earlier in females than in males.\"}]","Pre-diagnostic prescription patterns in bladder and renal cancer - a longitudinal linked data study - Abstract | PDF",1790006597]